On the record · Investment firm
Ampersand Capital Partners
Research depth
Transactions sourced
At least one recorded transaction has a public source.
Record updated Sept. 27, 2026
Current ownership
Current owner not established
This record does not identify a current owner. That absence is a gap in the record, not a conclusion about ownership.
Ownership and transaction history
Chronology from recorded ownership periods, transactions and reviewed outcome events. Event order does not imply causation.
Feb. 2, 2017
Corpus Medical, Inc. / Ampersand Capital Partners
Other · Completed · Recorded transaction
June 18, 2019
N2 Biomedical / Ampersand Capital Partners
Leveraged buyout · Completed · Recorded transaction
March 19, 2024
Biologos LLC / Ampersand Capital Partners
Leveraged buyout · Completed · Recorded transaction
Dec. 12, 2017
LakePharma / Ampersand Capital Partners, Summit Partners
Minority investment · Announced · Recorded transaction
March 20, 2018
Nexcelom Bioscience LLC / Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
March 26, 2018
MedPharm Ltd. / Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
Jan. 13, 2020
Interpace Biosciences, Inc. / 1315 Capital, Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
Nov. 17, 2021
Leinco Technologies / Ampersand Capital Partners
Leveraged buyout · Announced · Recorded transaction
Aug. 25, 2022
Phosphorex / Ampersand Capital Partners
Other · Announced · Recorded transaction
June 12, 2023
NanoImaging Services, Inc. / Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
April 17, 2025
Lexington Medical, Inc. / Ampersand Capital Partners
Minority investment · Announced · Recorded transaction
Sources and evidence
Recorded transaction sources
These support a recorded transaction row. They have not passed the separate evidence-review process.
- R1Ampersand Completes Growth Equity Investment In Corpus Medical
Ampersand Capital Partners · Company announcement · Feb. 2, 2017
Supports: Recorded transaction
- R2Ampersand Completes Growth Equity Investment In N2 Biomedical
Ampersand Capital Partners · Company announcement · June 18, 2019
Supports: Recorded transaction
- R3Ampersand Capital Partners Acquires Biologos
Ampersand Capital Partners · Company announcement · March 19, 2024
Supports: Recorded transaction
- R4Lakepharma Raises Growth Capital From Summit Partners And Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · Dec. 12, 2017
Supports: Recorded transaction
- R5Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · March 20, 2018
Supports: Recorded transaction
- R6MedPharm Receives Growth Equity Investment from Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · March 26, 2018
Supports: Recorded transaction
- R7Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · Jan. 6, 2020
Supports: Recorded transaction
- R8Leinco Technologies Receives Growth Equity Investment From Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · Nov. 17, 2021
Supports: Recorded transaction
- R9Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand
Ampersand Capital Partners · Company announcement · Aug. 25, 2022
Supports: Recorded transaction
- R10NanoImaging Services Receives Growth Equity Investment from Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · June 12, 2023
Supports: Recorded transaction
- R11Lexington Medical Secures Growth Investment from Ampersand Capital Partners
Ampersand Capital Partners · Company announcement · April 17, 2025
Supports: Recorded transaction
What we do not know
These are gaps in the public record, not findings about the organization.
- The organization's operating status has not been researched.
- No current public ownership assessment has been published.
Help improve this record
Firsthand experience, public sources and corrections can help close the gaps above.